Trial Profile
Examination for the effect of combination therapy with raloxifene and eldecalcitol in postmenopausal osteoporotic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2021
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary) ; Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 22 Mar 2021 Status changed from recruiting to completed.
- 18 Jan 2018 Planned End Date changed from 31 Mar 2016 to 31 Mar 2019.
- 07 Aug 2012 New trial record